Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.570
+0.025 (0.55%)
Aug 27, 2026, 5:35 PM CET
Faes Farma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 697.2 | 610.46 | 493.65 | 451.17 | 438.75 | 398.56 |
Other Revenue | 13.86 | 16.52 | 16.39 | 21.93 | 22.97 | 30.08 |
| 711.06 | 626.99 | 510.04 | 473.09 | 461.72 | 428.64 | |
Revenue Growth | 30.76% | 22.93% | 7.81% | 2.46% | 7.72% | 4.17% |
Cost of Revenue | 247.68 | 227.01 | 174.04 | 160.78 | 162.56 | 150.96 |
Gross Profit | 463.37 | 399.98 | 336 | 312.31 | 299.16 | 277.68 |
Selling, General & Admin | 197.94 | 170.29 | 132.55 | 121.66 | 115.89 | 86.78 |
Amortization of Goodwill & Intangibles | 37.31 | 29.03 | 20.32 | 19.4 | 19.27 | 17.26 |
Other Operating Expenses | 129.92 | 111.83 | 74.6 | 68.42 | 62.08 | 76.53 |
Operating Expenses | 365.17 | 311.15 | 227.47 | 209.47 | 197.23 | 180.57 |
Operating Income | 98.21 | 88.82 | 108.53 | 102.84 | 101.92 | 97.11 |
Interest Expense | -9.77 | -4.6 | - | - | -0.26 | -0.22 |
Currency Exchange Gain (Loss) | 0.4 | -0.27 | -0.77 | -0.66 | -0.05 | -0.05 |
Other Non Operating Income (Expenses) | 1.02 | 1.02 | 1.26 | 0.7 | 0.25 | -0.02 |
EBT Excluding Unusual Items | 90.35 | 84.98 | 109.02 | 102.88 | 101.86 | 96.82 |
Impairment of Goodwill | - | - | - | - | - | -0.3 |
Asset Writedown | 0.26 | 0.44 | -1.45 | -0.03 | -0.44 | -3.56 |
Pretax Income | 90.62 | 85.41 | 107.58 | 102.85 | 101.42 | 92.97 |
Income Tax Expense | 6.14 | 5.75 | -3.54 | 11.16 | 11.97 | 10.52 |
Earnings From Continuing Operations | 84.48 | 79.66 | 111.11 | 91.69 | 89.45 | 82.45 |
Minority Interest in Earnings | -0.3 | -0.03 | 0.25 | 0.21 | 0.05 | -0.06 |
Net Income | 84.18 | 79.63 | 111.36 | 91.9 | 89.5 | 82.39 |
Net Income to Common | 84.18 | 79.63 | 111.36 | 91.9 | 89.5 | 82.39 |
Net Income Growth | -20.09% | -28.49% | 21.17% | 2.69% | 8.63% | 13.56% |
Shares Outstanding (Basic) | 311 | 311 | 311 | 310 | 306 | 291 |
Shares Outstanding (Diluted) | 314 | 313 | 312 | 311 | 306 | 305 |
Shares Change | 0.43% | 0.20% | 0.56% | 1.57% | 0.36% | 4.38% |
EPS (Basic) | 0.27 | 0.26 | 0.36 | 0.30 | 0.29 | 0.28 |
EPS (Diluted) | 0.27 | 0.25 | 0.36 | 0.30 | 0.29 | 0.27 |
EPS Growth | -20.43% | -28.65% | 20.27% | 1.09% | 8.45% | 8.87% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 62.53 | 62.39 | 81.65 | 5.21 | 31.83 | 28.16 |
Free Cash Flow Per Share | 0.20 | 0.20 | 0.26 | 0.02 | 0.10 | 0.09 |
Dividend Per Share | 0.087 | 0.128 | 0.179 | 0.155 | 0.155 | 0.206 |
Dividend Growth | -51.40% | -28.49% | 15.48% | 0% | -24.76% | 4.57% |
Gross Margin | 65.17% | 63.79% | 65.88% | 66.02% | 64.79% | 64.78% |
Operating Margin | 13.81% | 14.17% | 21.28% | 21.74% | 22.07% | 22.66% |
Profit Margin | 11.84% | 12.70% | 21.83% | 19.43% | 19.38% | 19.22% |
Free Cash Flow Margin | 8.79% | 9.95% | 16.01% | 1.10% | 6.89% | 6.57% |
EBITDA | 125.74 | 112.16 | 124.57 | 118.53 | 117.97 | 111.24 |
EBITDA Margin | 17.68% | 17.89% | 24.42% | 25.05% | 25.55% | 25.95% |
D&A For EBITDA | 27.53 | 23.33 | 16.04 | 15.69 | 16.05 | 14.13 |
EBIT | 98.21 | 88.82 | 108.53 | 102.84 | 101.92 | 97.11 |
EBIT Margin | 13.81% | 14.17% | 21.28% | 21.74% | 22.07% | 22.66% |
Effective Tax Rate | 6.77% | 6.73% | - | 10.85% | 11.80% | 11.32% |
Advertising Expenses | - | 29.99 | 26.53 | 24.13 | 23.58 | - |